Skip to main content
logo
Profusa, Inc. (PFSA)
NASDAQ: PFSA · Real-Time Price · USD
0.3544
-0.0054 (-1.50%)
At close: May 29, 2026, 4:00 PM EDT
0.3649
+0.0105 (2.96%)
After-hours: May 29, 2026, 7:52 PM EDT

Company Description

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States.

It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery.

The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid.

Profusa, Inc. is based in Berkeley, California.

Profusa, Inc.
Profusa logo
CountryUnited States
Founded2009
IndustryMedical Devices
SectorHealthcare
Employees15
CEOBen Hwang

Contact Details

Address:
626 Bancroft Way, Suite A
Berkeley, California 94710
United States
Phone925 997 6925
Websiteprofusa.com

Stock Details

Ticker SymbolPFSA
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001859807
CUSIP Number74319X207
ISIN NumberUS74319X2071
Employer ID86-3437271
SIC Code3841

Key Executives

NamePosition
Dr. Ben Chung-Bin Hwang Ph.D.Chief Executive Officer and Chairman
Fred S. KnechtelChief Financial Officer
William McMillanCo-founder, Chief Scientific Officer and Head of Research
David IckeHead of Digital Health Business
Sean GivensHead of Government Business

Latest SEC Filings

DateTypeTitle
May 26, 2026ARSFiling
May 26, 2026DEF 14AOther definitive proxy statements
May 26, 20268-KCurrent Report
May 19, 2026424B3Prospectus
May 18, 20268-KCurrent Report
May 15, 202610-QQuarterly Report
May 15, 20268-KCurrent Report
May 12, 2026PRE 14AOther preliminary proxy statements
May 8, 20268-KCurrent Report
May 4, 2026EFFECTNotice of Effectiveness
View All SEC Filings